Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex

CHERRY HILL, N.J., May 27 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC
Bulletin Board: NVLX), an emerging healthcare consumer products company,
announced today that Infinitink(TM), the world's first permanent tattoo ink
designed to be both safe and more easily removed, is the subject of a June 1st
article in Time Magazine. The story, "Too Fickle for a Tattoo?" updates
readers on Infinitink, a product developed to address tattoo regret and
broaden the audience for this already popular art form.

"Artists report that new customers requesting Infinitink are most often part
of the 'fence-sitter' group, those who have considered getting a tattoo, but
have not gotten one because of concerns about permanence," said Martin
Schmieg, Chairman and CEO of Nuvilex, Inc. "According to market surveys, this
group represents 25% of the over 18-year-old U.S. population. Therefore, we
expect strong demand for our solution."

Infinitink was selected as one of Time Magazine's 'Products of the Year' in
its November 12, 2007 issue. Since then, Infinitink has undergone further
testing and development. Infinitink is now available throughout the United
States. To learn more about Infinitink, or to locate an artist, log onto
www.Infinitink.com.

About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products
company with a portfolio of aesthetics, dermatology, environmental and
nutraceutical products. The company's focus is on developing, licensing and
commercializing healthcare products that address the health needs of consumers
worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a
diversified skin products technology company serving the fast-growing body
art, aesthetic, cosmetic and skin therapy markets. More information is
available at: http://www.nuvilex.com or www.freedom2inc.com.

Safe Harbor Statement
Statements contained in this presentation that are not strictly historical are
"forward-looking" statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities and Exchange Act of
1934. The forward-looking statements are made based on information available
as of the date hereof, and the Company assumes no obligation to update such
forward-looking statements. Forward-looking statements are sometimes
identified by words such as "intends", "anticipates", "believes", "expects",
and "hopes" and involve a number of risks and uncertainties that could cause
the Company's actual results to differ materially from projected results. All
parties are cautioned that such forward-looking statements involve risks and
uncertainties that could cause the Company's actual results to differ
materially from those in these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company's products
and services, the planned share exchange with Freedom2 Holdings, Inc., our
ability to secure additional financing, and other factors that may be more
fully described in reports to shareholders and periodic filings with the
Securities and Exchange Commission.

Investor Relations Contacts:

Blair Barnes
Senior Vice President and Chief Financial Officer
Nuvilex, Inc.
Ph: 856-433-6088
Email: bbarnes@nuvilex.com

Stephanie Carrington/Amy Glynn
The Ruth Group
Ph: 646-536-7017/7023
Email: scarrington@theruthgroup.com
Email: aglynn@theruthgroup.com

Press Contact:

Pat Arcand
Arcand & Madison Public Relations
Ph: 617-576-7777
Email: pat@am-pr.com

SOURCE Nuvilex, Inc.

Investors, Blair Barnes, Senior Vice President and Chief Financial Officer of
Nuvilex, Inc., +1-856-433-6088, bbarnes@nuvilex.com, or Stephanie Carrington,
+1-646-536-7017, scarrington@theruthgroup.com, or Amy Glynn, +1-646-536-7023,
aglynn@theruthgroup.com, both of The Ruth Group for Nuvilex, Inc.; or Press,
Pat Arcand of Arcand & Madison Public Relations, +1-617-576-7777,
pat@am-pr.com, for Nuvilex, Inc.